BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  InnoCare Announces First Patient Dosed in Clinical Trial of Novel ADC ICP-B794 in China

  October 31, 2025

   · 

  2 min read
• Press Releases

  MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication

  October 31, 2025

   · 

  5 min read
• Press Releases

  Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates

  October 31, 2025

   · 

  1 min read
• Press Releases

  Sensient Declares Dividend - October 30, 2025

  October 31, 2025

   · 

  1 min read
• Press Releases

  Avenzo Therapeutics to Present Initial Results from the Phase 1 Study of AVZO-021, a Potential Best-in-Class CDK2 Inhibitor, at the 2025 San Antonio Breast Cancer Symposium

  October 31, 2025

   · 

  2 min read
• Press Releases

  Vizient Applauds FDA’s Recent Actions to Accelerate Biosimilar Development and Lower Costs

  October 31, 2025

   · 

  2 min read
• Press Releases

  Agilent to Announce Fourth-Quarter Fiscal Year 2025 Financial Results on Nov. 24

  October 31, 2025

   · 

  1 min read
• Press Releases

  Gilead Sciences Announces Third Quarter 2025 Financial Results

  October 31, 2025

   · 

  21 min read
• Press Releases

  Contineum Therapeutics Reports Third-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones

  October 31, 2025

   · 

  11 min read
• Press Releases

  Nuvation Bio to Participate in Upcoming Investor Conferences - October 30, 2025

  October 31, 2025

   · 

  1 min read